|
Diabetes, Vol 40, Issue 1 141-149, Copyright © 1991 by American Diabetes Association
Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans
FF Horber, HM Marsh and MW Haymond
Department of Pediatrics, Mayo Clinic, Rochester, Minnesota.
Human growth hormone (hGH) and prednisone cause insulin resistance and
glucose intolerance. However, it is unknown whether hGH and prednisone
antagonize insulin action on protein, fat, and carbohydrate metabolism by a
common or independent mechanism. Therefore, protein, fat, and carbohydrate
metabolism was assessed simultaneously in four groups of eight subjects
each after 7 days of placebo, recombinant DNA hGH (rhGH; 0.1
mg.kg-1.day-1), prednisone (0.8 mg.kg-1.day-1), or rhGH and prednisone
administration after an 18-h fast and during gut infusion of glucose and
amino acids (fed state). Fasting plasma glucose concentrations were similar
during placebo and rhGH but elevated (P less than 0.001) during combined
treatment, whereas plasma insulin concentrations were higher (237 +/- 57
pmol/ml, P less than 0.001) during combined than during placebo, rhGH, or
prednisone treatment (34, 52, and 91 pM, respectively). In the fed state,
plasma glucose concentrations were elevated only during combined treatment
(11.3 +/- 2.1 mM, P less than 0.001). Plasma insulin concentrations were
elevated during therapy with prednisone alone and rhGH alone (667 +/- 72
and 564 +/- 65 pmol/ml, respectively, P less than 0.001) compared with
placebo (226 +/- 44 pmol/ml) but lower than with the combined rhGH and
prednisone treatment (1249 +/- 54 pmol/ml, P less than 0.01). Protein
oxidation [( 14C]leucine) increased (P less than 0.001) with prednisone
therapy, decreased (P less than 0.001) with rhGH treatment, and was normal
during the combined treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Liu, D. M. Bravata, I. Olkin, A. Friedlander, V. Liu, B. Roberts, E. Bendavid, O. Saynina, S. R. Salpeter, A. M. Garber, et al.
Systematic Review: The Effects of Growth Hormone on Athletic Performance
Ann Intern Med,
May 20, 2008;
148(10):
747 - 758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Simon, A.-M. Prieur, P. Quartier, J. Charles Ruiz, and P. Czernichow
Early Recombinant Human Growth Hormone Treatment in Glucocorticoid-Treated Children with Juvenile Idiopathic Arthritis: A 3-Year Randomized Study
J. Clin. Endocrinol. Metab.,
July 1, 2007;
92(7):
2567 - 2573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Burt, J. Gibney, and K. K. Y. Ho
Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment
Am J Physiol Endocrinol Metab,
May 1, 2007;
292(5):
E1426 - E1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hiscock, C. P. Fischer, M. Sacchetti, G. van Hall, M. A. Febbraio, and B. K. Pedersen
Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans
Am J Physiol Endocrinol Metab,
July 1, 2005;
289(1):
E2 - E7.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. W. Petersen, A. L. Carey, M. Sacchetti, G. R. Steinberg, S. L. Macaulay, M. A. Febbraio, and B. K. Pedersen
Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro
Am J Physiol Endocrinol Metab,
January 1, 2005;
288(1):
E155 - E162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Darmaun, V. Hayes, D. Schaeffer, S. Welch, and N. Mauras
Effects of Glutamine and Recombinant Human Growth Hormone on Protein Metabolism in Prepubertal Children with Cystic Fibrosis
J. Clin. Endocrinol. Metab.,
March 1, 2004;
89(3):
1146 - 1152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. van Hall, A. Steensberg, M. Sacchetti, C. Fischer, C. Keller, P. Schjerling, N. Hiscock, K. Moller, B. Saltin, M. A. Febbraio, et al.
Interleukin-6 Stimulates Lipolysis and Fat Oxidation in Humans
J. Clin. Endocrinol. Metab.,
July 1, 2003;
88(7):
3005 - 3010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. A. Rooman, G. Kuijpers, R. Gresnigt, R. Bloemen, J. G. Koster, and S. C. van Buul-Offers
Dexamethasone Differentially Inhibits Thyroxine- or Growth Hormone-Induced Body and Organ Growth of Snell Dwarf Mice
Endocrinology,
June 1, 2003;
144(6):
2553 - 2558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Bush, D. G. Burrin, A. Suryawan, P. M. J. O'Connor, H. V. Nguyen, P. J. Reeds, N. C. Steele, J. B. Van Goudoever, and T. A. Davis
Somatotropin-induced protein anabolism in hindquarters and portal-drained viscera of growing pigs
Am J Physiol Endocrinol Metab,
February 1, 2003;
284(2):
E302 - E312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tigas, A. Sunehag, and M. W. Haymond
Metabolic Adaptation to Feeding and Fasting during Lactation in Humans
J. Clin. Endocrinol. Metab.,
January 1, 2002;
87(1):
302 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Reilly, M. Brougham, C. Montgomery, F. Richardson, A. Kelly, and B. E. S. Gibson
Effect of Glucocorticoid Therapy on Energy Intake in Children Treated for Acute Lymphoblastic Leukemia
J. Clin. Endocrinol. Metab.,
August 1, 2001;
86(8):
3742 - 3745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Long, L. Wei, and E. J. Barrett
Dexamethasone inhibits the stimulation of muscle protein synthesis and PHAS-I and p70 S6-kinase phosphorylation
Am J Physiol Endocrinol Metab,
April 1, 2001;
280(4):
E570 - E575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Vann, H. V. Nguyen, P. J. Reeds, N. C. Steele, D. R. Deaver, and T. A. Davis
Somatotropin increases protein balance independent of insulin's effects on protein metabolism in growing pigs
Am J Physiol Endocrinol Metab,
July 1, 2000;
279(1):
E1 - E10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Vann, H. V. Nguyen, P. J. Reeds, D. G. Burrin, M. L. Fiorotto, N. C. Steele, D. R. Deaver, and T. A. Davis
Somatotropin increases protein balance by lowering body protein degradation in fed, growing pigs
Am J Physiol Endocrinol Metab,
March 1, 2000;
278(3):
E477 - E483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ottosson, P. Lönnroth, P. Björntorp, and S. Edén
Effects of Cortisol and Growth Hormone on Lipolysis in Human Adipose Tissue
J. Clin. Endocrinol. Metab.,
February 1, 2000;
85(2):
799 - 803.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Schneeweiss, H. Lochs, C. Zauner, M. Fischer, J. Wyatt, T. Maier-Dobersberger, and B. Schneider
Energy and Substrate Metabolism in Patients with Active Crohn's Disease
J. Nutr.,
April 1, 1999;
129(4):
844 - 848.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Schneiter and L. Tappy
Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans
Am J Physiol Endocrinol Metab,
November 1, 1998;
275(5):
E806 - E813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Berneis, R. Ninnis, J. Girard, B. M. Frey, and U. Keller
Effects of Insulin-Like Growth Factor I Combined with Growth Hormone on Glucocorticoid-Induced Whole-Body Protein Catabolism in Man
J. Clin. Endocrinol. Metab.,
August 1, 1997;
82(8):
2528 - 2534.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1991 by the American Diabetes Association.
|
|
| |
|